SMN1 and cancer: Sarcopenia is described as a clinical manifestation of the cancer cachexia syndrome.17 CT analysis is increasingly used to assess surrogates of sarcopenia, including SMA, skeletal muscle index, and muscle radiation attenuation.36 In this cohort study, we found that low SMA was significantly associated with postoperative infectious complications and 5-year cancer recurrence.